Bank of America Highlights ServiceNow's Unique AI Advantage Amid Strong Q2 Performance
Finance

Bank of America Highlights ServiceNow's Unique AI Advantage Amid Strong Q2 Performance

authorBy Fareed Zakaria
DateJul 24, 2026
Read time3 min

ServiceNow recently delivered an impressive financial performance for its second quarter, surpassing the market's forecasts. Bank of America has since reaffirmed its optimistic outlook on the software company, maintaining a 'Buy' recommendation and setting a target price of $130 per share. This target suggests a substantial potential increase of approximately 36% from the stock's value noted in BofA's July 23rd analysis. The core of this positive assessment lies in ServiceNow's distinctive artificial intelligence capabilities, particularly its ability to leverage vast internal data to enhance AI agent performance and address complex business challenges more effectively.

ServiceNow's AI Agents: A Deep Dive into Their Distinctive Capabilities

On July 24, 2026, Bank of America's analyst, Tal Liani, highlighted a crucial, often overlooked aspect of ServiceNow's AI strategy. While ServiceNow's second-quarter subscription revenue soared by 24.5% to $3.88 billion and its current remaining performance obligations (CRO) increased by 21% to $13.2 billion—both exceeding Wall Street's projections—Liani pointed out that the true differentiator lies in ServiceNow's AI agents. These agents benefit immensely from the company's existing repository of workflow histories and infrastructure records. This internal data wealth allows ServiceNow's AI to provide contextual solutions to intricate enterprise problems, which often lack straightforward, documented answers.

For instance, tackling an application outage requires more than just following a predefined script. An AI agent might need to identify associated servers, review recent configuration changes, understand interdependencies with other services, and ascertain who has the authority for repairs. ServiceNow's Configuration Management Database (CMDB), which meticulously maps applications, servers, and their relationships, combined with its Context Engine, which integrates human roles, policies, and past decisions, empowers its AI agents to navigate such complex scenarios. This integrated approach significantly reduces the need for extensive data integration steps that third-party AI products typically require, thereby streamlining deployment and reducing operational complexity. The company's AI products have already surpassed $1 billion in annual contract value, with the number of customers utilizing its agentic AI in production increasing ninefold over the last nine months. Furthermore, upgrades to AI-native packages are driving price increases of 20% to 30%, indicating strong market adoption.

However, the journey for ServiceNow's AI is not without its hurdles. Key questions remain regarding the consistent reliability of its AI agents, customers' willingness to further expand their usage, and the company's capacity to offset the rising costs associated with running AI workloads. The second quarter saw a dip in gross margin to 77.9% from 81% a year prior, missing BofA's 79.3% estimate. This reduction signals that a larger portion of revenue is being allocated to product delivery costs, primarily due to increased AI adoption and the use of hyperscaler infrastructure. Despite these cost pressures, ServiceNow managed to maintain its full-year operating-margin forecast at 31.5% by offsetting expenses with stronger subscription revenue and strategic spending timing. The company forecasts third-quarter subscription revenue between $3.975 billion and $3.980 billion, slightly below analysts' expectations, partly due to some federal contract revenue being recognized earlier than anticipated.

Ultimately, ServiceNow's long-term success hinges on its ability to demonstrate that its AI agents can consistently resolve complex issues both accurately and cost-effectively, thereby expanding customer usage without further eroding gross margins. Bank of America's continued confidence underscores the potential, but also highlights the ongoing tests and strategic management required for this AI-driven growth.

More Articles
Finance
Utility Revenue Bonds: Funding Essential Public Services
Utility revenue bonds are a type of municipal bond used to finance public utility projects. Repayment to bondholders is directly sourced from the revenues generated by these projects, rather than general tax funds. These bonds often feature a net revenue pledge, prioritizing operational and maintenance costs before debt repayment. Investors assess these bonds using metrics like coverage ratio, population trends, and customer concentration to gauge their viability and risk.
By Mariana MazzucatoJul 24, 2026
Finance
Understanding the Concept of a Narrow Economic Moat
A narrow economic moat describes a business that possesses only a slight competitive edge over its industry rivals. Unlike a wide economic moat, which denotes a significant and enduring advantage, a narrow moat offers limited economic benefits and is typically short-lived due to intense competition. This concept, popularized by investor Warren Buffett, highlights the challenges companies face in highly competitive sectors with low barriers to entry and minimal intellectual property protection.
By Robert KiyosakiJul 24, 2026
Finance
American Airlines: Navigating Fuel Price Volatility and Bridging the Profitability Gap
Despite recent stock market fluctuations, American Airlines recorded impressive Q2 revenue. The company is actively addressing a significant profit disparity compared to its competitors through strategic growth initiatives, particularly in its loyalty program. While facing a projected surge in fuel costs by 2026, the airline's stock currently presents a compelling valuation relative to its future earnings potential, signaling an optimistic long-term outlook for investors.
By Strive MasiyiwaJul 24, 2026
Finance
Tarsus Pharmaceuticals: Overcoming Sales Dip and Anticipating Future Growth
Tarsus Pharmaceuticals, Inc. experienced its first sales decline for Xdemvy in Q1'26 since its launch, yet management remains confident in achieving its 2026 net sales guidance of $670M–$700M, supported by promising Q2'26 prescription data. The recent acquisition of iRenix Medical adds IRX-101 to its pipeline, diversifying its offerings. Furthermore, upcoming H1'27 trial readouts for Lyme disease prevention and ocular rosacea present significant catalysts for future expansion, all while the company maintains a robust cash position.
By Fareed ZakariaJul 24, 2026
Finance
Understanding Contingent Shares in Corporate Finance
Contingent shares are a type of stock issued under specific conditions, often linked to company performance or M&A outcomes. They incentivize management and can bridge valuation gaps in acquisitions, but may dilute existing shareholder ownership. This article explores their mechanics, benefits, and drawbacks with a practical example.
By Nouriel RoubiniJul 24, 2026